Publication | Closed Access

Initial report on intraves1cal administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder

Urological ResearchUrologySurgical OncologyGenitourinary CancerMedicineCancer TreatmentOncologyRadiation OncologyIntraves1cal AdministrationCancer ResearchAd 32Urinary Bladder